An illness–death multistate model to implement delta adjustment and reference‐based imputation with time‐to‐event endpoints

Author:

García‐Hernandez Alberto1ORCID,Pérez Teresa1,del Carmen Pardo María2,Rizopoulos Dimitris3

Affiliation:

1. Facultad de Estudios Estadísticos Univ. Complutense Madrid Spain

2. Facultad de Ciencias Matemáticas Univ. Complutense Madrid Spain

3. Department of Biostatistics Erasmus Medical Center Rotterdam The Netherlands

Abstract

AbstractWith a treatment policy strategy, therapies are evaluated regardless of the disturbance caused by intercurrent events (ICEs). Implementing this estimand is challenging if subjects are not followed up after the ICE. This circumstance can be dealt with using delta adjustment (DA) or reference‐based (RB) imputation. In the survival field, DA and RB imputation have been researched so far using multiple imputation (MI). Here, we present a fully analytical solution. We use the illness–death multistate model with the following transitions: (a) from the initial state to the event of interest, (b) from the initial state to the ICE, and (c) from the ICE to the event. We estimate the intensity function of transitions (a) and (b) using flexible parametric survival models. Transition (c) is assumed unobserved but identifiable using DA or RB imputation assumptions. Various rules have been considered: no ICE effect, DA under proportional hazards (PH) or additive hazards (AH), jump to reference (J2R), and (either PH or AH) copy increment from reference. We obtain the marginal survival curve of interest by calculating, via numerical integration, the probability of transitioning from the initial state to the event of interest regardless of having passed or not by the ICE state. We use the delta method to obtain standard errors (SEs). Finally, we quantify the performance of the proposed estimator through simulations and compare it against MI. Our analytical solution is more efficient than MI and avoids SE misestimation—a known phenomenon associated with Rubin's variance equation.

Funder

Ministerio de Ciencia e Innovación

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Reference57 articles.

1. International Council for Harmonisation (ICH) of technical requirements for pharmaceuticals for human use. ICH E9 (R1) Addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials. Adopted on 20 November 2019https://database.ich.org/sites/default/files/E9-R1_Step4_Guideline_2019_1203.pdf[Last accessed 4‐Dec‐2021]

2. Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation

3. A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials

4. Choosing estimands in clinical trials with missing data

5. Missing Data: Turning Guidance Into Action

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3